Cardinal Health, Q3
Cardinal Health Third Quarter 2024 Earnings: Misses Expectations
Cardinal Health's (CAH) third-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.
Cardinal Health, Inc. (NYSE:CAH) Q3 2024 Earnings Call Transcript
May 2, 2024 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $2.08, expectations were $1.95. Cardinal Health, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Cardinal Health Q3 Earnings: Undervalued On Strong Guidance
Cardinal Health exceeds Q3 earnings expectations, raises guidance, and shows potential for growth in the pharmaceutical and specialty business segments. See more.
Cardinal Health 3Q Earnings Top Views, Co Boosts FY24 Adj EPS View
By Rob Curran Cardinal Health's fiscal third-quarter operating earnings smashed Wall Street targets and the drug wholesaler boosted its adjusted
Cardinal Health Inc Q3 Profit Decreases, but beats estimates
Cardinal Health Inc (CAH) reported earnings for third quarter that decreased from last year but beat the Street estimates. The
Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View
Cardinal Health's (CAH) third-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.
MarketBeat on MSN6h
For Cardinal Health, the Proof Will be in Its Performance
Investors are familiar with the phrase "buy the rumor, sell the news." However, Cardinal Health Inc. (NYSE: CAH) proved that ...
Reuters1d
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
Total sales came in at $54.91 billion, missing analysts' estimates of $56.06 billion. Cardinal Health said last month its ...
Cardinal Health’s stock falls on mixed quarterly results
Cardinal Health’s shares fell premarket Thursday after the company reported mixed quarterly results but raised its full-year ...
Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance
Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2024 revenues of $54.9 billion, an increase of 9% from ...
MassDevice4d
FDA issues warning letter to Cardinal Health for adulterated and misbranded medical devices
Dublin, Ohio-based Cardinal Health was found to be marketing convenience kits containing certain piston syringes manufactured ...
Drug Store News1d
Cardinal Health reports growth in Q3 revenue, raises fiscal year 2024 non-GAAP EPS guidance
Cardinal Health’s third quarter revenue increased 9% to $54.9 billion.
Plastics News2d
FDA warns Cardinal Health on use of imported syringes
The U.S. Food and Drug Administration has warned health care giant Cardinal Health over sales of imported plastic syringes ...
Apple, Cardinal Health Among 12 Companies To Announce Dividend Increases In First Half Of May
Eleven long-term dividend growth companies announced their annual dividend increases in the second half of April. Read more ...